MedTrace Logo

HIV Testing in Pregnant Women: Evaluating an Opt-Out Testing Strategy

NCT00393302 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1074

Last updated 2019-02-22

No results posted yet for this study

Summary

Mother-to-child transmission of HIV is an important but preventable mode of infection. Prevention depends on identifying pregnant women infected with HIV and offering medications during pregnancy which can dramatically decrease the chances of transmission. Currently universal screening of all pregnant women for HIV is recommended in the province of Ontario. Unfortunately the rates of screening are still low: estimates place the average rate at 50% -60%. We believe that rates in our clinic at the Women's Health Care Centre are significantly higher in part because all our patients have a first obstetrical visit. This is an unhurried visit with a trained obstetrical nurse who offers pre-test counselling and explores reasons why patients refuse testing. We hypothesize that with this system, acceptance rates for HIV screening are significantly higher than the provincial average.

Conditions

  • HIV
  • AIDS Virus
  • Pregnancy

Interventions

PROCEDURE

HIV screening in pregnancy

Sponsors & Collaborators

  • Unity Health Toronto

    lead OTHER

Principal Investigators

  • Mark H Yudin, MD MSc · St. Michael's Hospital & the University of Toronto

Eligibility

Min Age
16 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-09-30
Primary Completion
2006-01-31
Completion
2006-02-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00393302 on ClinicalTrials.gov